Professor Brandon Wainwright
Professor

Brandon Wainwright

Email: 
Phone: 
*

Background

Professor Brandon Wainwright AM is Co-Director of the Children’s Brain Cancer Centre and leads a laboratory within the UQ Diamantina Institute focused on understanding the genetic pathways behind medulloblastoma, a type of brain tumour that occurs predominantly in children. He is Chair of the European Molecular Biology Laboratory (EMBL) Australia, Chair of the Advisory Board of the Robinson Research Institute and Chair of the Board of the South Australian Immunogenomics Cancer Institute (SAIGENCI), and serves on the boards the Australian Genome Research Facility as well as several national and international scientific review committees, including the MRFF Brain Tumour Roadmap Committee.

Professor Wainwright completed his undergraduate and postgraduate studies at The University of Adelaide, after which he secured a postdoctoral fellowship with St Mary's Hospital at Imperial College London. During his six years at Imperial he worked on the first human genome project and also became a Medical Research Council Senior Research Fellow. He returned to Australia in 1990 to join UQ's Centre for Molecular and Cellular Biology (now IMB) and led the Institute for Molecular Biology until 2019.

Professor Wainwright is a geneticist, renowned for discovering the genetic pathway that causes most human cancer. He is skilled in molecular genetics, where he is using genetic approaches to dig through DNA and find the genes that cause disease. He commenced using these skills to locate the cystic fibrosis gene, but it was when isolating a gene responsible for a rare form of brain cancer called Medulloblastoma, that he discovered the role of the ‘Hedgehog Pathway' in common human cancer.

Availability

Professor Brandon Wainwright is:
Available for supervision
Media expert

Fields of research

Biological Sciences Clinical sciences Oncology and carcinogenesis

Research interests

  • Cancer and cell signalling

    Skin cancer is a major public health issue in Australia, with the treatment of non-melanoma skin cancer costing our community more than $264 million each year. Moreover, brain tumours remain the most common cause of cancer-related death in children and of these, medulloblastoma is the most commonly diagnosed. Our laboratory has made great progress in understanding the genetic pathways behind the most common form of skin cancer in Australia, Basal Cell Carcinoma (BCC), and medulloblastoma, a type of brain tumour that occurs predominantly in children. Having mapped and isolated the Naevoid Basel Cell Carcinoma Syndrome (NBCCS) gene called Patched, which is the driver for a medical condition where affected individuals have a predisposition for developing BCC and medulloblastoma, we were able to identify the Patched gene as a controller of a molecular signalling pathway called the Hedgehog pathway. The Hedgehog pathway is a set of genetic mutations that contribute to the development of a wide range of tumour types, including lung, pancreatic and ovarian cancer. By examining this pathway and how it interacts with other genetic pathways, our scientists have gained a better understanding of the normal development of the skin and cerebellum, a part of the brain that controls motor functions. By manipulating the strength of the Hedgehog pathway we believe stem cell populations can be expanded or can be induced to become cancerous. Our lab has identified the core genetic components that lead to the development of medulloblastoma. This work will enable the therapeutic targeting of every medulloblastoma, not just a subset, leading to more powerful clinical trials and ultimately more effective treatment options.

Search Professor Brandon Wainwright’s works on UQ eSpace

168 works between 1985 and 2024
All (168) Journal Article (148) Conference Publication (20)

121 - 140 of 168 works

1998

Journal Article

No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types

Wicking, C, Evans, T, Henk, B, Hayward, N, Simms, LA, Chenevix-Trench, G, Pietsch, T and Wainwright, B (1998). No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types. Oncogene, 16 (8), 1091-1093. doi: 10.1038/sj.onc.1201644

No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types

1998

Journal Article

Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice

Smith, Stephen N., Delaney, Stephen J., Dorin, Julia R., Farley, Raymond, Geddes, Duncan M., Porteous, David J., Wainwright, Brandon J. and Alton, Eric W. F. W. (1998). Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice. American Journal of Physiology - Cell Physiology, 274 (2 43-2), C492-C499. doi: 10.1152/ajpcell.1998.274.2.c492

Effect of IBMX and alkaline phosphatase inhibitors on Cl- secretion in G551D cystic fibrosis mutant mice

1998

Conference Publication

Novel susceptibility gene for NIDDM is localised to human chromosome 12q

Shaw, JTE, Lovelock, PK, Duffy, D, Cardinal, J, Berkholz, JR, Kesting, JB and Wainwright, B (1998). Novel susceptibility gene for NIDDM is localised to human chromosome 12q. NEW YORK: SPRINGER VERLAG.

Novel susceptibility gene for NIDDM is localised to human chromosome 12q

1997

Journal Article

Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes

Richards, Frances M., Goudie, David R., Cooper, Wendy N., Jene, Quitz, Barroso, Inês , Wicking, Carol, Wainwright, Brandon J. and Ferguson-Smith, Malcolm A. (1997). Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes. Human Genetics, 101 (3), 317-322. doi: 10.1007/s004390050635

Mapping the multiple self-healing squamous epithelioma (MSSE) gene and investigation of xeroderma pigmentosum group A (XPA) and PATCHED (PTCH) as candidate genes

1997

Journal Article

Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome

Lench, NJ, Telford, EAR, High, AS, Markham, AF, Wicking, C and Wainwright, BJ (1997). Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome. Human Genetics, 100 (5-6), 497-502. doi: 10.1007/s004390050541

Characterisation of human patched germ line mutations in naevoid basal cell carcinoma syndrome

1997

Journal Article

Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched

Pietsch, T, Waha, A, Koch, A, Kraus, J, Albrecht, S, Tonn, J, Sorensen, N, Berthold, F, Henk, B, Schmandt, N, Wolf, HK, vonDeimling, A, Wainwright, B, ChenevixTrench, G, Wiestler, OD and Wicking, C (1997). Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Research, 57 (11), 2085-2088.

Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched

1997

Journal Article

Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours

Shih, Yang-Chia, Kerr, Judith, Liu, Jim, Hurst, Terry, Khoo, Soo-Keat, Ward, Bruce, Wainwright, Brandon and Chenevix-Trench, Georgia (1997). Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours. International Journal of Cancer, 70 (5), 508-511. doi: 10.1002/(SICI)1097-0215(19970304)70:53.0.CO;2-1

Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours

1997

Journal Article

Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins

Holmes, G, Boterashvili, S, English, M, Wainwright, B, Licht, J and Little, M (1997). Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins. Biochemical and Biophysical Research Communications, 233 (3), 723-728. doi: 10.1006/bbrc.1997.6545

Two N-terminal self-association domains are required for the dominant negative transcriptional activity of WT1 Denys-Drash mutant proteins

1997

Journal Article

No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung

Suzuki, K, Daigo, Y, Fukuda, S, Tokino, T, Isomura, M, Isono, K, Wainwright, B and Nakamura, Y (1997). No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung. Japanese journal of cancer research : Gann, 88 (3), 225-8. doi: 10.1111/j.1349-7006.1997.tb00370.x

No evidence of mutation in the human PTC gene, responsible for nevoid basal cell carcinoma syndrome, in human primary squamous cell carcinomas of the esophagus and lung

1997

Journal Article

Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident

Wicking, Carol, Shanley, Susan, Smyth, Ian, Gillies, Susan, Negus, Kylie, Graham, Scott, Suthers, Graeme, Haites, Neva, Edwards, Matt, Wainwright, Brandon and Chenevix-Trench, Georgia (1997). Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. American Journal of Human Genetics, 60 (1), 21-26.

Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident

1997

Journal Article

Pulsed-field gel electrophoresis and FISH mapping of chromosome 9q22: Placement of a novel zinc finger gene within the NBCCS and ESS1 region

Levanat, S, Chidambaram, A, Wicking, C, BrayWard, P, Pressman, C, Toftgard, R, Gailani, MR, Myers, JC, Wainwright, B, Dean, M and Bale, AE (1997). Pulsed-field gel electrophoresis and FISH mapping of chromosome 9q22: Placement of a novel zinc finger gene within the NBCCS and ESS1 region. Cytogenetics and Cell Genetics, 76 (3-4), 208-213. doi: 10.1159/000134551

Pulsed-field gel electrophoresis and FISH mapping of chromosome 9q22: Placement of a novel zinc finger gene within the NBCCS and ESS1 region

1997

Journal Article

De novo mutations of the patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype

Wicking, C., Gillies, S., Smyth, I., Shanley, S., Fowles, L., Ratcliffe, J., Wainwright, B. and Chenevix-Trench, G. (1997). De novo mutations of the patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype. American Journal of Medical Genetics Part A, 73 (3), 304-307. doi: 10.1002/(SICI)1096-8628(19971219)73:33.0.CO;2-N

De novo mutations of the patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype

1996

Journal Article

Targeted disruption of the Wnt2 gene results in placentation defects

Monkley, Susan J., Delaney, Stephen J., Pennisi, David J., Christiansen, Jeffrey H. and Wainwright, Brandon J. (1996). Targeted disruption of the Wnt2 gene results in placentation defects. Development, 122 (11), 3343-3353. doi: 10.1242/dev.122.11.3343

Targeted disruption of the Wnt2 gene results in placentation defects

1996

Journal Article

A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction

Dorin, J. R., Farley, R., Webb, S., Smith, S. N., Farini, E., Delaney, S. J., Wainwright, B. J., Alton, E. W.F.W. and Porteous, D. J. (1996). A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Therapy, 3 (9), 797-801.

A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction

1996

Journal Article

A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers

Little, MH, Holmes, G, Pell, L, Caricasole, A, Duarte, A, Law, M, Ward, A and Wainwright, B (1996). A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers. Oncogene, 13 (7), 1461-1469.

A novel target for the Wilms' tumour suppressor protein (WT1) is bound by a unique combination of zinc fingers

1996

Journal Article

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

Hahn, H, Wicking, C, Zaphiropoulos, PG, Gailani, MR, Shanley, S, Chidambaram, A, Vorechovsky, , Holmberg, E, Unden, AB, Gillies, S, Negus, K, Smyth, , Pressman, C, Leffell, DJ, Gerrard, B, Goldstein, AM, Dean, M, Toftgard, R, ChenevixTrench, G, Wainwright, B and Bale, AE (1996). Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell, 85 (6), 841-851. doi: 10.1016/S0092-8674(00)81268-4

Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome

1996

Journal Article

A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities

Hahn, Heidi, Christiansen, Jeffrey, Wicking, Carol, Zaphiropoulos, Peter G., Chidambaram, Abirami, Gerrard, Bernard, Vorechovsky, Igor, Bale, Allen E., Toftgard, Rune, Dean, Michael and Wainwright, Brandon (1996). A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities. Journal of Biological Chemistry, 271 (21), 12125-12128. doi: 10.1074/jbc.271.21.12125

A mammalian patched homolog is expressed in target tissues of sonic hedgehog and maps to a region associated with developmental abnormalities

1996

Journal Article

Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations

Delaney, Stephen J., Alton, Eric W.F.W., Smith, Stephen N., Lunn, Dominic P., Farley, Ray, Lovelock, Paul K., Thomson, Scott A., Hume, David A., Lamb, David, Porteous, David J., Dorin, Julia R. and Wainwright, Brandon J. (1996). Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations. EMBO Journal, 15 (5), 955-963. doi: 10.1002/j.1460-2075.1996.tb00432.x

Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations

1996

Journal Article

New pharmaceutical approaches to the treatment of cystic fibrosis. Gene therapy for cystic fibrosis is advancing rapidly but drug therapy is quickly catching up (pages 467-469)

Delaney, Stephen J. and Wainwright, Brandon J. (1996). New pharmaceutical approaches to the treatment of cystic fibrosis. Gene therapy for cystic fibrosis is advancing rapidly but drug therapy is quickly catching up (pages 467-469). Nature Medicine, 2 (4), 392-393. doi: 10.1038/nm0496-392

New pharmaceutical approaches to the treatment of cystic fibrosis. Gene therapy for cystic fibrosis is advancing rapidly but drug therapy is quickly catching up (pages 467-469)

1996

Journal Article

+P5(D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21->q22

Negus, K, Holmes, GH, Wicking, C, Wainwright, BJ and Little, MH (1996). +P5(D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21->q22. Cytogenetics and Cell Genetics, 72 (4), 306-309. doi: 10.1159/000134210

+P5(D1S3309E), a novel target binding site for the Wilms' tumour suppressor 1 (WT1) gene, maps to human chromosome 1q21->q22

Current funding

  • 2024 - 2029
    Building mRNA Cancer Vaccines for Australia.
    MRFF - National Critical Infrastructure Initiative
    Open grant
  • 2023 - 2027
    A vaccine to treat paediatric brain cancer
    The Trustee for the Robert Connor Dawes Foundation
    Open grant
  • 2019 - 2025
    Centre for Child and Adolescent Brain Cancer Research
    The Children's Hospital Foundation
    Open grant

Past funding

  • 2023 - 2024
    Engineering Immune Recognition of Paediatric Brain Tumours
    Walter & Eliza Hall Institute of Medical Research (WEHI)
    Open grant
  • 2022 - 2024
    A new combination therapy for children with brain cancer
    Soiree For a Cure
    Open grant
  • 2022 - 2024
    A new and effective combination therapy for children with brain cancer (TKCP)
    The Kid's Cancer Project
    Open grant
  • 2021 - 2023
    Targeting and eliminating paediatric cancers with chimeric antigen receptor engineered natural killer cells, a new hope for cancer immunotherapy
    Children's Hospital Foundation Immunotherapy Research Grants
    Open grant
  • 2021 - 2024
    Identification of therapy-resistant cells driving relapse in Medulloblastoma from integrated spatial transcriptomics and tissue imaging
    NHMRC IDEAS Grants
    Open grant
  • 2019 - 2021
    Developing treatments for vincristine-induced neuropathy
    The Kid's Cancer Project
    Open grant
  • 2019 - 2022
    Exploiting CDK4/6 inhibition to treat medulloblastoma.
    Cancer Australia
    Open grant
  • 2019 - 2020
    Liquid biopsy (CSF) in paediatric brain cancer patients
    Brainchild Foundation
    Open grant
  • 2017 - 2024
    ACRF Cancer Ultrastructure and Function Facility
    Australian Cancer Research Foundation
    Open grant
  • 2016 - 2019
    Targeting the cell cycle regulators CDK4/6 to treat medulloblastoma
    The Kid's Cancer Project
    Open grant
  • 2016 - 2019
    Cure Brain Cancer Foundation Donation
    Cure Brain Cancer Foundation
    Open grant
  • 2016 - 2021
    Preparing Australia for Genomic Medicine: A proposal by the Australian Genomics Health Alliance (NHMRC Targeted Call for Research administered by Murdoch Children's Research Institute)
    Murdoch Childrens Research Institute
    Open grant
  • 2016
    4D Mass Spectrometer
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2017
    A Synthetic lethal based approach for the treatment of medulloblastoma
    Cancer Council Queensland
    Open grant
  • 2014 - 2016
    Establishment of patient-derived xenografts from paediatric brain tumours to facilitate a personalised genomic approach to treatment
    Brainchild Foundation
    Open grant
  • 2012 - 2014
    Identification of genes causing medulloblastoma by transposon mutagenesis.
    NHMRC Project Grant
    Open grant
  • 2010 - 2012
    The intersection between hedgehog and notch signalling in medulloblastoma.
    NHMRC Project Grant
    Open grant
  • 2010 - 2013
    The primary cilium in hedgehog signalling and disease
    NHMRC Project Grant
    Open grant
  • 2009 - 2016
    The ACRF Cancer Biology Imaging Facility
    Australian Cancer Research Foundation
    Open grant
  • 2009 - 2014
    International Cancer Genome Consortium
    NHMRC Medical Bioinformatics Genomics Proteomics Program
    Open grant
  • 2009 - 2012
    Dissecting the role of hedgehog signalling in chondrogenesis and skeletal disease
    NHMRC Project Grant
    Open grant
  • 2008 - 2009
    Kruppel-like factors in cell cycle control and cancer
    Cancer Council Queensland
    Open grant
  • 2008 - 2010
    Patched gene family control of epidermal development and cancer
    NHMRC Project Grant
    Open grant
  • 2008 - 2009
    Profiling the pro- and anti-inflammatory functions of histone deacetylases in macrophages
    Cancer Council Queensland
    Open grant
  • 2007 - 2008
    The Cellular Origin of Medulloblastoma
    Queensland Cancer Fund
    Open grant
  • 2006
    Advanced Cell Labelling and Imaging Facility
    ARC Linkage Infrastructure, Equipment and Facilities
    Open grant
  • 2006 - 2008
    ERRgamma and skeletal muscle: Insights into lipid utilization and catabolism
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    Hedgehog signalling in limb and craniofacial development and disease
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    Molecular genetics of the host response defect in cystic fibrosis
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    NR1 nuclear hormone receptors, and skeletal muscle metabolism: Insights into dyslipidemia and metabolic disease.
    NHMRC Project Grant
    Open grant
  • 2004 - 2011
    Dynamic Imaging Facility for Cancer Biology
    Australian Cancer Research Foundation
    Open grant
  • 2004 - 2006
    The role of patched/hedgehog signalling in common human cancer
    NHMRC Project Grant
    Open grant
  • 2003
    Agilent Microarray Scanner
    NHMRC Equipment Grant
    Open grant
  • 2003
    Alternative Splicing in the Mouse Transcriptome
    ARC Discovery Projects
    Open grant
  • 2003 - 2005
    Molecular genetics of cystic fibrosis
    NHMRC Project Grant
    Open grant
  • 2003 - 2005
    Regulation Of Hedgehog Signalling Through Intracellular Trafficking Events
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    Conditional Knockout of the Murine Patched Gene for the Study of Skin Differentiation and Cancer
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    The Downstream Targets of Patched Hedgehog Signalling
    NHMRC Project Grant
    Open grant
  • 2001 - 2003
    The identification of the downstream targets of patched/hedgehog signalling
    Queensland Cancer Fund
    Open grant
  • 2000 - 2002
    Genes controlling the development of lung disease in cystic fibrosis mutant mice
    NHMRC Project Grant
    Open grant
  • 2000 - 2014
    State Government Funds
    Queensland Department of Employment, Economic Development and Innovation
    Open grant
  • 1999 - 2001
    Analysis and correction of the host response defect in cystic fibrosis G551D mice
    NHMRC Project Grant
    Open grant
  • 1999
    Avalanche microscanner
    NHMRC Equipment Grant
    Open grant
  • 1999 - 2000
    Targets of the patched/hedgehog signalling pathway in basal cell carcinoma of the skin and other solid tumours
    Queensland Cancer Fund
    Open grant
  • 1998 - 2000
    Inactivation of the Patched Tumour Suppressor Gene in the Skin of Transgenic Mice
    NHMRC Project Grant
    Open grant
  • 1998 - 2000
    Structure-Function Analysis of the PATCHED Tumour Suppressor Gene Product
    NHMRC Project Grant
    Open grant
  • 1998 - 1999
    The smoothened gene in skin development and tumour formation
    Queensland Cancer Fund
    Open grant
  • 1997 - 1999
    Genes controlling the development of lung disease in normal and cystic fibrosis mice
    NHMRC Project Grant
    Open grant
  • 1997 - 1998
    Mouse models for naevoid basal cell carcinoma syndrome and basal cell carcinoma
    Queensland Cancer Fund
    Open grant
  • 1997 - 1998
    The role of PTC, the naevoid basal cell carcinoma syndrome gene, in carcigenesis
    Queensland Cancer Fund
    Open grant
  • 1996 - 1998
    Correction of the ion channel defect in the airway of cystic fibrosis G551D mice
    NHMRC Project Grant
    Open grant
  • 1996
    Suppression of tumorigenicity in medulloblastoma
    Cancer Bequest Fund
    Open grant
  • 1995 - 1997
    Actions and interactions of the four alternately spliced WT1 protein isoforms
    NHMRC Project Grant - Standard
    Open grant
  • 1995
    Identification of cis-acting elements in the murine CFTR promoter
    UQ External Support Enabling Grant
    Open grant
  • 1995
    Identification of cis-acting elements in the murine CFTR promoter.
    Australian Cystic Fibrosis Research Trust
    Open grant
  • 1995 - 1997
    The isolation of the naevoid basal cell carcinoma syndrome gene
    NHMRC Project Grant - Standard
    Open grant
  • 1995
    Travel to attend the North American CF Conference, October 1995 and to confer with colleagues in the USA & UK.
    Royal Alexandra Hospital for Children - Camperdown
    Open grant

Availability

Professor Brandon Wainwright is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    New treatments for children with medulloblastoma.

    Principal Advisor

  • Doctor Philosophy

    New treatments for children with medulloblastoma.

    Principal Advisor

  • Doctor Philosophy

    The role of the blood brain barrier in the successful treatment of brain tumours in children

    Principal Advisor

  • Doctor Philosophy

    A new therapy for paediatric brain tumours.

    Principal Advisor

    Other advisors: Dr Joseph Yunis

  • Doctor Philosophy

    Complex neoantigen prediction in cancers

    Associate Advisor

  • Doctor Philosophy

    Investigation into network-defined novel targeted therapies for medulloblastoma

    Associate Advisor

    Other advisors: Dr Laura Genovesi

  • Doctor Philosophy

    Investigation into network-defined novel targeted therapies for medulloblastoma

    Associate Advisor

    Other advisors: Dr Laura Genovesi

Completed supervision

Enquiries

Contact Professor Brandon Wainwright directly for media enquiries about:

  • brain cancer
  • brain tumour
  • genetics
  • genomics
  • health research
  • medical research
  • medulloblastoma
  • science policy
  • scientific leadership
  • skin cancer
  • tumours

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au